IA
AMRX icon

IndexIQ Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

IndexIQ Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$407K Buy
97,631
+34,881
+56% +$154K 0.01% 569
2021
Q4 		$301K Sell
62,750
-4,055
-6% -$20.2K 0.01% 946
2021
Q3 		$357K Buy
66,805
+6,691
+11% +$33.7K 0.01% 905
2021
Q2 		$308K Sell
60,114
-150
-0.2% -$853 0.01% 971
2021
Q1 		$406K Buy
+60,264
New +$334K 0.01% 556

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IndexIQ Advisors's AMRX Position: Q1 2022 in Review

IndexIQ Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 56% in Q1 2022, buying an estimated $154K and bringing the position to 97,631 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #569.

IndexIQ Advisors first reported a position in AMRX in Q1 2021 and has held it in 5 quarters since. 168 funds tracked by Wall St. Rank hold AMRX as of Q1 2022.

  • IndexIQ Advisors held 97,631 shares of Amneal Pharmaceuticals worth $407K as of Q1 2022.
  • IndexIQ Advisors bought 34,881 Amneal Pharmaceuticals shares in Q1 2022, an estimated $154K.
  • Amneal Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #569 holding.
  • IndexIQ Advisors first reported a position in Amneal Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
  • 168 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.